Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Metabolic syndrome is estimated to affect more than one in five adults, and its prevalence is growing in the adult and pediatric populations. The most widely recognized metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Individuals with these c...
Saved in:
Main Authors: | Francisco A. Monsalve, Radha D. Pyarasani, Fernando Delgado-Lopez, Rodrigo Moore-Carrasco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/549627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01) -
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
by: Maryam Rakhshandehroo, et al.
Published: (2010-01-01) -
Peroxisome proliferator–activated receptor delta and liver diseases
by: Tomoo Yamazaki, et al.
Published: (2025-02-01) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01) -
Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01)